-
Product Insights
NewAesthetic Injectables Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Aesthetic Injectables Pipeline Market Report Overview Aesthetic injectables are gel-like substances injected beneath the skin to restore a youthful appearance by increasing the volume of sunken cheeks or temples or reducing lines around the nose and mouth, among other processes. Aesthetic Injectables are grouped into segments based on their molecular composition. The aesthetic injectables pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Product Insights
NewDecompensated Cirrhosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Decompensated Cirrhosis Clinical Trial Report Overview A total of 227 Decompensated Cirrhosis clinical trials were conducted as of April 2024. The Decompensated Cirrhosis Clinical Trial report provides an overview of the Decompensated Cirrhosis Clinical Trial scenario. This report provides top-line data relating to the clinical trials on Decompensated Cirrhosis. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Product Insights
Innovations in Aesthetic Injectables – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Aesthetic Injectables - Global Pipeline Summary" provides comprehensive information about the Aesthetic Injectables pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Aesthetic Injectables report provides key information and data related to: Extensive coverage of the Aesthetic Injectables under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories,...
-
Innovation Ranking
Innovation Ranking – Histogen Inc
Histogen Inc (Histogen), formerly Conatus Pharmaceuticals Inc is a biotechnology company that develops and commercializes novel medicines for the treatment of liver diseases. The company’s lead pipeline candidate includes emricasan, an orally active pan-caspase protease inhibitor which is designed to reduce the activity of human caspases and is intended for the treatment of various indications such as post-orthotopic liver transplant, nonalcoholic steatohepatitis (NASH) cirrhosis, and NASH fibrosis. Its other preclinical product candidates include IDN-7314, a pan-caspase inhibitor intended for the...
-
Product Insights
Cartilage Repair Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Cartilage Repair Pipeline Market Report Overview Cartilage repair procedures aim to regenerate, restore or replace articular cartilage to reduce joint pain and to prevent the development of arthritis. Cartilage repair interventions can occur early in the spectrum of joint damage and offer an opportunity for patients to delay or altogether avoid needing total joint replacement surgery. The cartilage repair pipeline market research report provides comprehensive information about the cartilage repair pipeline products with a comparative analysis of the products at...
-
Product Insights
Aesthetic Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Aesthetic Devices Pipeline Market Report Overview Aesthetic devices refer to the devices that are used in cosmetic procedures for beautification, correction and improvement of body contour which includes fillers, breast implants, facial implants and penile implants. The Aesthetic devices pipeline market research report provides comprehensive information about the aesthetic devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Aesthetic Injectables ·      ...
-
Company Profile
Histogen Inc – Company Profile
Histogen Inc (Histogen), formerly Conatus Pharmaceuticals Inc is a biotechnology company that develops and commercializes novel medicines for the treatment of liver diseases. The company’s lead pipeline candidate comprises emricasan, an orally active pan-caspase protease inhibitor which is designed to reduce the activity of human caspases and is intended for the treatment of various indications such as post-orthotopic liver transplant, nonalcoholic steatohepatitis (NASH) cirrhosis, and NASH fibrosis. Its other preclinical product candidates include IDN-7314, a pan-caspase inhibitor intended for the...
Add to Basket -
Sector Analysis
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022
COVID-19 Analyst Consensus Sales Report Overview Prophylactic COVID-19 vaccines are projected to generate total sales of $264 billion from 2021 to 2028. The number of COVID-19 drugs with forecast sales nearly tripled due to the massive mandatory vaccination campaigns led by the major markets, which caused rapid increases in COVID-19 vaccines. BioNTech/Pfizer’s Comirnaty, Moderna’s Spikevax, and Pfizer’s Paxlovid are the top three marketed drugs with the highest peak forecast sales. Comparing Q4 2020 and H2 2022 total COVID-19 forecast sales within...
-
Product Insights
Net Present Value Model: HST-003
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model HST-003 Drug Details HST-003 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HST-003
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry HST-003 Drug Details HST-003 is under development for joint cartilage regeneration in knee osteoarthritis...